Instant Intel: Ketryx $39M Series B Boosts Compliance Pipeline

🚀 Battle Card: Ketryx

• Erez Kaminski, Founder & CEO 📧 erez@ketryx.com

• AI-driven compliance platforms are attracting major VC dollars as life sciences teams race to meet FDA regulations faster and more transparently. → Source

• Fragmented development tools cause traceability gaps

• Manual documentation slows time to market

• Primary: Connected ALM integration → Single source of truth & automated compliance across tools

• Expansion: AI-driven compliance agents → 90% reduction in manual workload & faster FDA approvals

• HQ: Somerville, MA, USA

• Employees: ≈ 75

• Rev: ≈ $10 M

• Website: ketryx.com

🤼 Competitive Intel

• MasterControl — eQMS / ALM
• Unique edge: End-to-end document control for FDA-regulated processes
• Evaluated by QA & Regulatory Affairs for audit readiness

• Greenlight Guru — Medical Device QMS
• Unique edge: Industry-specific compliance workflows
• Evaluated by R&D & Quality teams for ease of use

• Veeva Systems — Quality & Compliance Cloud
• Unique edge: Tailored life sciences CRM + QMS integration
• Evaluated by VP Quality for platform scalability

• Qualio — Cloud QMS
• Unique edge: User-friendly interface for small biotechs
• Evaluated by COO & Compliance Officers for rapid deployment

• Arena Solutions — PLM / QMS
• Unique edge: Centralized BOM & change management
• Evaluated by IT & Engineering for system consolidation

✅ Do-Now Checklist

Next Step

🧠 Copy My Prompt for Personalized Cold Outreach

────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY   = ❑<your company>❑
OFFER_BRIEF   = ❑<1-line value>❑
PROOF_METRIC  = ❑<metric>❑
CTA_STYLE     = ❑quick_call | case_study❑
TONE          = ❑friendly | punchy❑

────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME        = Erez
COMPANY     = Ketryx
DEPT        = R&D
SIZE        = ≈ TBD
BOTTLENECK  = manual documentation slows time to market
EVENT       = Pulls In $39M Series B Funding Round
DETAIL      = Pulls In $39M Series B Funding Round
PAIN        = Fragmented development tools cause traceability gaps
SRC         = https://vcnewsdaily.com/ketryx/venture-capital-funding/scyvvcqhvg
SIM_CO      = ≈ TBD
WIN_METRIC  = 90% reduction in manual work
NEXT_SIZE   = ≈ TBD
EMP_EST     = ≈ 75
REV_EST     = ≈ $10M

────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.

Validate any ≈ guesses via SRC.

EMAIL  (keep breaks):
Subject: ≈ TBD-person R&D

Erez—noticed your R&D team is ≈ TBD.

That’s when manual documentation slows time to market.

We helped ≈ TBD fix this with ❑<1-line value>❑.

Result: 90% reduction in manual work.  
<<CTA_STYLE=="quick_call" ? "Quick call?" : "Want the 2-min recap?">>

PS—next bottleneck hits ≈ ≈ TBD.

DM ≤45 words, TONE:
Saw your post about Pulls In $39M Series B Funding Round — Fragmented development tools cause traceability gaps.  
❑<1-line value>❑. ❑<metric>❑.  
<<CTA_STYLE=="quick_call" ? "Quick chat?" : "Send case study?" >>